The global cutaneous T-cell lymphoma treatment landscape is undergoing rapid evolution due to advancements in studies. A broad range of {therapeuticoptions are now available, covering traditional methods such as topical medications and phototherapy, to more cutting-edge treatments like chemotherapy. Moreover, clinical trials are continually evaluat